1-3 of 3
Gavin Halbert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos, Joaquin Mateo, Jessica S. Brown, Alvaro H. Ingles Garces, Ruth Ruddle, Shaun Decordova, Simone Jueliger, Roberta Ferraldeschi, Oscar Maiques, Victoria Sanz-Moreno, Paul Jones, Stephanie Traub, Gavin Halbert, Sarah Mellor, Karen E. Swales, Florence I. Raynaud, Michelle D. Garrett, Udai Banerji
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (18): 4777–4784.
https://doi.org/10.1158/1078-0432.CCR-20-0700
Published: 15 September 2020
View article titled, First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors
Open the PDF for First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors

Malcolm Ranson, Mark R. Middleton, John Bridgewater, Siow Ming Lee, Martin Dawson, Debra Jowle, Gavin Halbert, Sue Waller, Helen McGrath, Lindsey Gumbrell, R. Stanley McElhinney, Dorothy Donnelly, T. Brian H. McMurry, Geoffrey P. Margison
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1577–1584.
https://doi.org/10.1158/1078-0432.CCR-05-2198
Published: 06 March 2006
View article titled, Lomeguatrib, a Potent Inhibitor of <em>O</em><sup>6</sup>-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors
Open the PDF for Lomeguatrib, a Potent Inhibitor of <em>O</em><sup>6</sup>-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors in another window
Journal Articles

A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy

Beatrice M. Seddon, Geoffrey S. Payne, Laura Simmons, Ruth Ruddle, Rachel Grimshaw, Siew Tan, Alison Turner, Florence Raynaud, Gavin Halbert, Martin O. Leach, Ian Judson, Paul Workman
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5101–5112.
Published: 12 November 2003
View article titled, A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy
Open the PDF for A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy in another window